Archives of Clinical Infectious Diseases

Published by: Kowsar

Viral Load as a Predictor of Severity in Crimean-Congo Hemorrhagic Fever

Maliheh Metanat 1 , Batool Sharifi Mood 1 , Masoud Salehi 1 , * , Alireza Ansari Moghaddam 2 , Mohammad Rakhshani 1 and Nahid Sepehri Rad 1
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: January 2017, 12 (1); e39068
  • Published Online: November 5, 2016
  • Article Type: Research Article
  • Received: May 10, 2016
  • Revised: October 1, 2016
  • Accepted: October 5, 2016
  • DOI: 10.5812/archcid.39068

To Cite: Metanat M, Sharifi Mood B, Salehi M, Ansari Moghaddam A, Rakhshani M, et al. Viral Load as a Predictor of Severity in Crimean-Congo Hemorrhagic Fever, Arch Clin Infect Dis. 2017 ; 12(1):e39068. doi: 10.5812/archcid.39068.

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Sharifi-Mood B, Metanat M, Ghorbani-Vaghei A, Fayyaz-Jahani F, Akrami E. The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study. Arch Iran Med. 2009; 12(2): 151-3[PubMed]
  • 2. Metanat M, Sharifi-Mood B, Salehi M, Alavi-Naini R. Clinical Outcomes in Crimean-Congo Hemorrhagic Fever: A Five-years Experience in the Treatment of Patients in Oral Ribavirin. Int J Virol. 2006; 2: 21-4[DOI]
  • 3. Onguru PD, Bodur H, Yilmaz M. Coagulopathy parameters in patients with Crimean- Congo, Hemorrhagic fever and its relation with mortality. J Clin Laboratory Analysis. 2010; 24: 163-6
  • 4. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol. 1979; 15(4): 307-417[PubMed]
  • 5. Tabatabaei SM, Hassanzehi A, Pakzad A, Mohammdi M, Madani A. Factors Influencing Crimean-Congo Hemorrhagic Fever Risk Perceptions in the General Population, Southeast Iran. Int J Infect. 2014; 1(1): 18150[DOI]
  • 6. Emadi Koochak H, Yalda AR, Haj Abdolbagh M, Sood Bakhsh A. Crimean-Congo Hemorrhagic Fever. Tehran Univ Med J. 2003; 61(5): 343-58
  • 7. Sharifi-Mood B, Alavi-Naini R, Metant M. Ten yeatrs after the beginning of the Crimean-Congo Haemorrhagic Fever outbreak in Iran: A promising repor. Iran J Clin Infect Dis. 2009; 4(3): 189-19
  • 8. van Eeden PJ, Joubert JR, van de Wal BW, King JB, de Kock A, Groenewald JH. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part I. Clinical features. S Afr Med J. 1985; 68(10): 711-7[PubMed]
  • 9. Mehrabi-Tavana A, Chinikar S, Mazaheri V. The seroepidemiological aspects of Crimean-Congo hemorrhagic fever in three healthcare workers: a report from Iran. Arch Iranian Med. 2002; 255-8(5): 3
  • 10. Yilmaz G, Koksal I, Topbas M, Yilmaz H, Aksoy F. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria. J Clin Virol. 2010; 47(4): 361-5[DOI][PubMed]
  • 11. Metanat M, Sharifi-Mood B, Tabatabaei M, Sarraf-Shirazi M. Can Serum Ferritin Level Predict Disease Severity in Patients with Crimean-Congo Hemorrhagic Fever? Eurasian J Med. 2013; 45: 108-14
  • 12. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect. 2006; 12(6): 551-4[DOI][PubMed]
  • 13. Mardani M, Keshtkar-Jahromi M. Crimean-Congo hemorrhagic fever. Arch Iran Med. 2007; 11(3): 204-14
  • 14. Cevik MA, Erbay A, Bodur H, Gulderen E, Bastug A, Kubar A, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis. 2008; 12(4): 374-9[DOI][PubMed]
  • 15. Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med. 2004; 32(12): 2416-21[DOI]
  • 16. Cevik MA, Erbay A, Bodur H, Eren SS, Akinci E, Sener K, et al. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis. 2007; 45(7): 96-100[DOI][PubMed]
  • 17. Duh D, Saksida A, Petrovec M, Ahmeti S, Dedushaj I, Panning M, et al. Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg Infect Dis. 2007; 13(11): 1769-72[DOI][PubMed]
  • 18. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis. 2006; 193(7): 941-4[DOI][PubMed]
  • 19. Hasanoglu I, Guner R, Carhan A, Kocak Tufan Z, Yagci-Caglayik D, Guven T, et al. Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: Viral load. J Clin Virol. 2016; : 42-6[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments